Search
for
Sort by
Research 421–450 of 1000+
- Diagnostic approach to low‐renin hypertension
- Polycystic Ovarian Syndrome in Adolescents
- Estimation methods for human circadian phase by use of peripheral tissues
- Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Anatomy and Physiology of the Skin
- Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions
- Development of a Chitosan Nanofibrillar Scaffold for Skin Repair and Regeneration
- Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin Aging
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Physiological and biological skin changes in pregnancy
- Effective high-throughput isolation of enriched platelets and circulating pro-angiogenic cells to accelerate skin-wound healing
- Maternal and neonatal hair mercury concentrations: the effect of dental amalgam
- Effects of Guasha on histomorphology of scraped skins and on expression of calcitonin gene-related peptide and substance P in rats
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Androgen excess is the key element in polycystic ovary syndrome
- Evidence-based approach to cutaneous hyperandrogenism in women
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- Women's midlife health Reframing menopause
- Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet
- Contraception and the dermatologist
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Clinical Trials and Hair Loss
- Androgen replacement therapy in women
- Factors associated with early-onset androgenetic alopecia: A scoping review
- Androgen excess: a hallmark of polycystic ovary syndrome
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW